Related references
Note: Only part of the references are listed.The proton pump inhibitor test for gastroesophageal reflux disease: Optimal cut-off value and duration
Annalisa de Leone et al.
DIGESTIVE AND LIVER DISEASE (2010)
Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study
John Dent et al.
GUT (2010)
Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care - prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg
A. Eggleston et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease
R. Fass et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Diagnosis and Management of Non-Erosive Reflux Disease - The Vevey NERD Consensus Group
I. M. Modlin et al.
DIGESTION (2009)
Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease
Toru Hiyama et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage
A. J. Bredenoord et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
A Randomized, Comparative Trial of a Potassium-Competitive Acid blocker (AZD0865)and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease
John Dent et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Proton pump inhibitors: the beginning of the end or the end of the beginning?
Carmelo Scarpignato et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study
R. M. Zagari et al.
GUT (2008)
Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease
Naomi Uemura et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Impedance-pH monitoring: new standard for measuring gastro-oesophageal reflux
A. J. Bredenoord
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Role of endoscopy in the management of GERD
David R. Lichtenstein et al.
GASTROINTESTINAL ENDOSCOPY (2007)
The montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus
Nimish Vakil et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Review article: the opportunities and benefits of extended acid suppression
C. Scarpignato et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis
Charles J. Lightdale et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Functional esophageal disorders
Jean Paul Galmiche et al.
GASTROENTEROLOGY (2006)
Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease
PJ Kahrilas et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: A randomized, placebo-controlled trial
DA Johnson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Review article: gastro-oesophageal reflux disease - the extent of the problem
P Moayyedi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease
Y Fujiwara et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: A randomized, double-blind study in urban Asia
K. M. Fock et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Heartburn-dominant, uninvestigated dyspepsia:: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care -: the CADET-HR Study
D Armstrong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis
MB Fennerty et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population:: A Kalixanda study report
J Ronkainen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Quality of life assessment in gastro-oesophageal reflux disease
EJ Irvine
GUT (2004)
40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms
A Gillessen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease
WM Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
The role of acid suppression in patients with endoscopy-negative reflux disease:: the effect of treatment with esomeprazole or omeprazole
D Armstrong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Effectiveness of Proton Pump Inhibitors in Nonerosive Reflux Disease
Bonnie B. Dean et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease
J van Zyl et al.
DIGESTION (2004)
Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms
T Scholten et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Correct and incorrect dosing of proton pump inhibitors and its impact an GERD symptoms
JP Pezanoski et al.
GASTROENTEROLOGY (2003)
Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn
F Johnsson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Non-erosive reflux disease (NERD) - acid reflux and symptom patterns
SD Martinez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis
PO Katz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis - Results of a multinational study
T Korner et al.
DIGESTION (2003)
Functional heartburn: the stimulus, the pain, and the brain
R Fass et al.
GUT (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial
CJJ Mulder et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Relationship between acid reflux episodes and gastroesophageal reflux symptoms is very inconstant
E Colas-Atger et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate
UG Meneghelli et al.
DISEASES OF THE ESOPHAGUS (2002)
Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis
KD Bardhan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Comparison of pantoprazole 20 mg to ranitidine 150 mg bid in the treatment of mild gastroesophageal reflux disease
S Kaspari et al.
DIGESTION (2001)
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial
PJ Kahrilas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia
B Kaplan-Machlis et al.
ARCHIVES OF FAMILY MEDICINE (2000)
Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis
JE Richter et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study
JH van Zyl et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2000)
Share Paper
